Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3 - Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	11 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,785,376	2.16%	680,874	0.53%
(2)	Derivatives (other than options):
		354,221	0.27%	604,791	0.47%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:
		3,139,597	2.44%	1,285,665	1.00%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	12	203.1120 USD
Purchase	31	199.8000 USD
Purchase	45	202.9550 USD
Purchase	74	199.5500 USD
Purchase	100	199.5900 USD
Purchase	100	203.5575 USD
Purchase	100	203.1100 USD
Purchase	100	203.0300 USD
Purchase	100	202.8200 USD
Purchase	100	200.3700 USD
Purchase	100	199.7600 USD
Purchase	116	203.6224 USD
Purchase	120	200.5333 USD
Purchase	200	200.5050 USD
Purchase	200	199.5950 USD
Purchase	202	199.8326 USD
Purchase	209	203.5156 USD
Purchase	228	200.5430 USD
Purchase	328	200.3384 USD
Purchase	351	199.7570 USD
Purchase	390	199.9289 USD
Purchase	457	199.9140 USD
Purchase	485	203.4359 USD
Purchase	520	200.0726 USD
Purchase	625	200.0232 USD
Purchase	700	203.5389 USD
Purchase	1,000	199.7155 USD
Purchase	1,010	199.7740 USD
Purchase	1,218	200.1866 USD
Purchase	3,212	199.2300 USD
Purchase	4,134	200.0881 USD
Purchase	4,242	200.1138 USD
Purchase	6,567	200.1119 USD
Purchase	6,922	200.0934 USD
Purchase	7,137	201.7453 USD
Purchase	8,422	199.8021 USD
Purchase	12,974	201.2478 USD
Purchase	18,337	202.4577 USD
Purchase	32,305	201.3094 USD
Purchase	39,748	203.1446 USD
Sale	2	203.4300 USD
Sale	11	202.6472 USD
Sale	25	201.4100 USD
Sale	45	202.9550 USD
Sale	65	199.5500 USD
Sale	100	202.8500 USD
Sale	106	203.0177 USD
Sale	122	202.9150 USD
Sale	194	202.6825 USD
Sale	198	203.5638 USD
Sale	200	201.7950 USD
Sale	200	203.3125 USD
Sale	200	202.9800 USD
Sale	259	202.8301 USD
Sale	300	203.3650 USD
Sale	425	202.8407 USD
Sale	1,256	203.1103 USD
Sale	1,927	203.1284 USD
Sale	2,902	202.1232 USD
Sale	4,242	200.1138 USD
Sale	6,712	201.7083 USD
Sale	6,717	201.6243 USD
Sale	6,792	200.8114 USD
Sale	7,229	199.2300 USD
Sale	8,542	203.0101 USD
Sale	9,136	203.2162 USD
Sale	9,586	203.1582 USD
Sale	9,822	203.2203 USD
Sale	16,213	202.3648 USD
Sale	29,693	201.5101 USD
Sale	30,000	199.9878 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	14 Jan 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection